Canada Markets closed

Heat Biologics, Inc. (HTBX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
5.43-0.17 (-3.04%)
At close: 4:00PM EDT
5.57 +0.14 (+2.58%)
After hours: 07:50PM EDT
Full screen
Loading interactive chart...
  • GlobeNewswire

    Heat Biologics Appoints Paul Tebbey as Senior Vice President of Product Development and Portfolio Strategy

    DURHAM, N.C., Oct. 06, 2021 (GLOBE NEWSWIRE) -- Heat Biologics, Inc. (“Heat”) (NASDAQ: HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, today announced the appointment of Paul Tebbey, Ph.D. as Senior Vice President of Product Development and Portfolio Strategy. Dr. Tebbey is a pharmaceutical development strategy leader with over 25 years of healthcare and management experience across the biotechnology and pharmaceutic

  • GlobeNewswire

    Heat Biologics CEO to Present at the Cantor Fitzgerald Global Healthcare Conference on September 29th

    DURHAM, N.C., Sept. 15, 2021 (GLOBE NEWSWIRE) -- Heat Biologics, Inc. (Nasdaq: HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, today announced that Jeff Wolf, Chief Executive Officer of Heat Biologics, will be presenting at the Cantor Fitzgerald Global Healthcare Conference being held virtually between September 27-30, 2021. Presentation Details:Date: Wednesday, September 29, 2021Time: 9:20 AM ET / 6:20 AM PTWebcast:

  • GlobeNewswire

    Heat Biologics to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

    DURHAM, N.C., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Heat Biologics, Inc. (Nasdaq: HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, today announced that Jeff Wolf, Chief Executive Officer of Heat Biologics, will be presenting at the H.C. Wainwright 23rd Annual Global Investment Conference being held virtually between September 13-15, 2021. Heat Biologics' presentation will be available on-demand to registered attendees vi